All In Biotech

Drug Trial Radar · NCT03213457

A Clinical Study to Evaluate the Safety and Efficacy of Elagolix in Participants With Moderate to Severe Endometriosis-Associated Pain

A Phase 3 Study to Evaluate the Safety and Efficacy of Elagolix in Combination With Estradiol/Norethindrone Acetate in Subjects With Moderate to Severe Endometriosis-Associated Pain

Last checked: Nov 19, 2026Latest source record: Dec 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 681 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

681

Actual

Start

Jul 7, 2017

Primary completion

Mar 27, 2020

Study completion Dec 6, 2023

Sponsor

Lead sponsor
AbbVieAbbVie (ABBV)
Sponsor type
Industry
First posted
Jul 11, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years, up to 49 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this study is to evaluate safety and efficacy of elagolix in the management of moderate to severe endometriosis-associated pain in adult premenopausal female participants including the safety and efficacy of elagolix in combination with concomitant hormonal add-back therapy.

Conditions

  • Endometriosis

Interventions

  • Estradiol/Norethindrone AcetateDrug

    Tablets

  • Placebo for ElagolixDrug

    Tablet

  • ElagolixDrug

    Tablet

  • Placebo for E2/NETADrug

    Tablets

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Co-Primary Endpoint: Percentage of Participants With a Response for Dysmenorrhea (DYS) at Months 6 and 12 Based on Daily AssessmentTime frame: Month 6, Month 12
  2. Co-Primary Endpoint: Percentage of Participants With a Response for Non-menstrual Pelvic Pain (NMPP) at Months 6 and 12 Based on Daily AssessmentTime frame: Month 6, Month 12

Locations

197 sites in 3 countries. Site status is shown where the registry gives one.

  • Central Research Associates /ID# 163087

    Birmingham, Alabama

  • Alabama Clinical Therapeutics, LLC /ID# 145503

    Birmingham, Alabama

  • Alabama Clinical Therapeutics, LLC /ID# 151468

    Birmingham, Alabama

  • Southern Women's Specialists PC /ID# 148750

    Fairhope, Alabama

  • Women's Health Alliance of Mobile /ID# 150083

    Mobile, Alabama

  • University of South Alabama /ID# 148774

    Mobile, Alabama

  • Mobile, Ob-Gyn, P.C. /ID# 145364

    Mobile, Alabama

  • Mesa Obstetricians and Gynecologists /ID# 147320

    Mesa, Arizona

  • Arizona Research Assoc /ID# 161703

    Tucson, Arizona

  • Eclipse Clinical Research /ID# 155600

    Tucson, Arizona

  • Unity Health- Searcy Medical Center /ID# 203674

    Searcy, Arkansas

  • Core Healthcare Group /ID# 149321

    Cerritos, California

  • HRC Fertility /ID# 154143

    Encino, California

  • Glendale Adventist Medical Ctr /ID# 160530

    Glendale, California

  • HCP Clinical Research LLC /ID# 152045

    Huntington Beach, California

  • Alliance Research Centers /ID# 151240

    Irvine, California

  • Long Beach Clinical Trial Serv /ID# 152428

    Long Beach, California

  • Olympia Clinical Trials /ID# 202325

    Los Angeles, California

  • California Medical Research As /ID# 154746

    Northridge, California

  • Futura Research, Org /ID# 145406

    Norwalk, California

  • Huntington Medical Foundation /ID# 154750

    Pasadena, California

  • Northern California Research /ID# 159753

    Sacramento, California

  • Precision Research Institute - San Diego /ID# 152557

    San Diego, California

  • MD Strategies Research Centers /ID# 152429

    San Diego, California

  • Alta California Medical Group /ID# 155706

    Simi Valley, California

  • Downtown Womens Health Care /ID# 147955

    Denver, Colorado

  • Advanced Women's Health Institute /ID# 145396

    Greenwood Village, Colorado

  • Red Rocks OB/GYN /ID# 145325

    Lakewood, Colorado

  • The Women's Health Group - Thornton /ID# 203707

    Thornton, Colorado

  • James A. Simon, MD, PC /ID# 145480

    Washington D.C., District of Columbia

  • Helix Biomedics, LLC /ID# 147108

    Boynton Beach, Florida

  • Gulf Coast Research Group /ID# 162895

    Brandon, Florida

  • Olympian Clinical Research /ID# 148167

    Clearwater, Florida

  • Omega Research Maitland, LLC /ID# 145167

    DeBary, Florida

  • KO Clinical Research, LLC /ID# 145410

    Fort Lauderdale, Florida

  • Clinical Physiology Associates /ID# 145237

    Fort Myers, Florida

  • Solutions Through Adv Rch /ID# 148768

    Jacksonville, Florida

  • Vida Clinical Research /ID# 150282

    Kissimmee, Florida

  • Axcess Medical Center /ID# 148169

    Loxahatchee Groves, Florida

  • Genoma Research Group, Inc /ID# 152558

    Miami, Florida

Showing 40 of 197 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.